AMIX — Autonomix Medical, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1617867 ·
Last close
$1.08
Market Cap
$2.21M
52W High
$24.68
52W Low
$0.93
ADV30
2,549,898
Next earnings
—
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -3,177,000 -3,126,000 8,195,000 7,692,000 1,254,000
Jun 2026 0 — -2,770,000 -2,728,000 3,980,000 3,460,000 818,000
Mar 2026 0 — -2,737,000 -2,666,000 7,600,000 7,004,000 1,705,000
Dec 2025 0 — -3,343,000 -3,261,000 10,211,000 9,934,000 1,650,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-13,222,000
Investing CF
$-10,000
Financing CF
$8,103,000
CapEx
$-7,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-64.25
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-69,822,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-16,148,000
Pretax Income TTM
$-16,106,000
Interest Exp TTM
$0
Analysts
2

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Mar 2026 0 -17,034,000 -16,715,000 7,600,000 1,705,000 5,895,000 -12,282,000
Mar 2025 0 -11,588,000 -11,410,000 9,806,000 1,707,000 8,099,000 -8,258,000
Mar 2024 0 -7,474,000 -15,426,000 9,407,000 1,779,000 7,628,000 -6,648,000
Mar 2023 0 -1,990,000 -1,990,000 865,000 221,000 644,000 -1,854,000

TTM Snapshot

Revenues TTM
$277,000
NetIncome TTM
$-16,106,000
OpCashFlow TTM
—
Assets (Latest)
$3,980,000
Forward EPS
$-7.40

Peers — same industry

TickerNameMarket CapLastDaily %
NUWE Nuwellis, Inc. $2.22M $4.10 —
CODX Co-Diagnostics, Inc. $2.06M $0.20 —
BJDX Bluejay Diagnostics, Inc. $2.41M $2.15 —
DROR Dror Ortho-Design, Inc. $2.44M $0.00 —
NXL Nexalin Technology, Inc. $1.85M $1.50 —

News headlines (Yahoo Finance, 1h cache)

Autonomix Highlights Renal Denervation Strategy and Vision for Illuminating the Nervous System at TCT 2026
2026-11-12 13:30 · Yahoo
Autonomix Medical Granted New U.S. Patent Strengthening Proprietary Catheter-Based Sensing Technology
2026-11-10 19:30 · Yahoo
Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
2026-10-02 12:05 · Yahoo
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
2026-09-30 12:30 · Yahoo
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
2026-09-24 12:30 · Yahoo
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
2026-09-16 12:30 · Yahoo
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
2026-09-01 12:30 · Yahoo
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
2026-08-26 12:30 · Yahoo
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
2026-08-25 01:06 · Yahoo
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
2026-08-12 12:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.